FDA · Drugs · Wednesday, September 2

Levothyroxine Sodium Tablets recall

ACCORD HEALTHCARE, INC. recalled Levothyroxine Sodium Tablets on September 2, 2026 because of subpotent drug. It was sold nationwide.

Why it was recalled

Subpotent Drug

What's recalled

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

Quantity: N/A

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice

Details

Company: ACCORD HEALTHCARE, INC., Raleigh, NC
Date: Wednesday, September 2
Severity: Class II
the product could cause temporary or reversible health problems.
Where sold: Nationwide
Nationwide within the United States
Status: Ongoing
Recall number: D-0781-2026
Source: U.S. Food and Drug Administration

More drugs recalls

TRP The Relief Products* Gentle Eyes Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Clear Eyes Redness Relief
Wed, Sep 30 · Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Lubricant Eye Drops-Cameron Pharmaceuticals
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Reliable -1 Laboratories
Wed, Sep 30 · Sterling Pharmaceutical Services LLC